U.S. Markets closed

BofA Turns Bearish On Livent After Bullish Conference Call

Jayson Derrick

Shares of lithium producer Livent Corp (NYSE: LTHM) gained more than 30% after hosting a bullish second-quarter conference call, but one analyst is skeptical on the company's outlook.

The Analyst

Bank of America Merrill Lynch's Steve Byrne downgraded Livent from Neutral to Underperform with a price target lowered from $10 to $7.

The Thesis

Livent issued an in-line second-quarter report Aug. 6, but during the conference call, the company discussed an acceleration in lithium hydroxide orders, Byrne said in a Monday downgrade note. (See his track record here.)

Bulls have been waiting for signs of an inflection point, but firsthand checks and research suggest the market for electric vehicles won't grow enough to absorb the company's new capacity over the next six to 12 months, the analyst said. 

Livent guided to a 2019 lithium hydroxide market size of 100-110kmt, more than triple the 30kmt market seen in 2018, he said. 

A more appropriate estimate for the size of the market in 2019 is 45-70kmt, Byrne said, adding that the industry could struggle to absorb another 50-60kmt of new supply coming online in 2020.

No rationale exists for turning bullish on Livent's 2019 outlook, and there is some reason to turn bearish on the 2020 story, Byrne said. 

Livent could be impacted by further decrements in realized lithium hydroxide price in a "creeping commoditization" market, according to BofA. 

Price Action

Livent shares were down 11.81% at $6.68 at the time of publication Monday. 

Related Links:

Munster Gives His Quick Take On Netflix, Livent And More

As Electric Car Makers Ramp Production, Lithium ETF Is Compelling Way To Participate

Latest Ratings for LTHM

Date Firm Action From To
Aug 2019 Downgrades Neutral Underperform
May 2019 Downgrades Buy Hold
May 2019 Downgrades Buy Neutral

View More Analyst Ratings for LTHM
View the Latest Analyst Ratings

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.